Evidence map›Paper›PMID 31201319›Full record

ArticleNature communications2019

Convergent allostery in ribonucleotide reductase.

William C Thomas, F Phil Brooks, Audrey A Burnim, John-Paul Bacik, JoAnne Stubbe, Jason T Kaelber, James Z Chen, Nozomi Ando

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 36 citations in OpenAlex.

  1. Hypermutability ofEmerging microbes & infections · 2025
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Small-angle X-ray scattering studies of enzymes.Current opinion in chemical biology · 2023
    Review
  7. Allosteric crosstalk in modular proteins: Function fine-tuning and drug design.Computational and structural biotechnology journal · 2023
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Radicals in Biology: Your Life Is in Their Hands.Journal of the American Chemical Society · 2021
    Article
  13. Article
  14. A ribonucleotide reductase fromThe Journal of biological chemistry · 2020
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

William C ThomasDepartment of Chemistry and Chemical Biology, Cornell University, Ithaca, NY, 14853, USA.
F Phil BrooksDepartment of Chemistry, Princeton University, Princeton, NJ, 08544, USA.
Audrey A BurnimDepartment of Chemistry and Chemical Biology, Cornell University, Ithaca, NY, 14853, USA.ORCID http://orcid.org/0000-0002-9962-1397
John-Paul BacikDepartment of Chemistry and Chemical Biology, Cornell University, Ithaca, NY, 14853, USA.
JoAnne StubbeDepartment of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.
Jason T KaelberInstitute for Quantitative Biomedicine, Rutgers University, Piscataway, NJ, 08854, USA.ORCID http://orcid.org/0000-0001-9426-1030
James Z ChenDepartment of Biochemistry and Molecular Biology, Oregon Health & Science University, Portland, OR, 97239, USA.
Nozomi AndoDepartment of Chemistry and Chemical Biology, Cornell University, Ithaca, NY, 14853, USA. nozomi.ando@cornell.edu.
Princeton University · USMassachusetts Institute of Technology · USOregon Health & Science University · USRutgers, The State University of New Jersey · US

Funding

Training and OutreachP30GM124166 · NIGMS · CORNELL UNIVERSITY · PI RICHARD A. CERIONE · 2019 to 2026
$28.3M
Overall (pp. 40-62)P41GM103485 · NIGMS · CORNELL UNIVERSITY · PI CERIONE, RICHARD A. · 2012 to 2018
$15.5M
Protein Allostery and Catalysis Beyond Bragg DiffractionR35GM124847 · NIGMS · PRINCETON UNIVERSITY · PI Nozomi Ando · 2017 to 2026
$4.1M
Ribonucleotide Reductase Regulation: Diferric Y* assembly/maintenance and Sml1R01GM081393 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI STUBBE, JOANNE · 2008 to 2016
$3.9M
National Science Foundation (NSF) DMR-1332208NIGMS NIH HHS P30 GM124166NIGMS NIH HHS P41 GM103485NIGMS NIH HHS R01 GM081393NIGMS NIH HHS R35 GM124847U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) GM081393U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) GM103485U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) GM124847
6 · The paper itself

Abstract

Ribonucleotide reductases (RNRs) use a conserved radical-based mechanism to catalyze the conversion of ribonucleotides to deoxyribonucleotides. Within the RNR family, class Ib RNRs are notable for being largely restricted to bacteria, including many pathogens, and for lacking an evolutionarily mobile ATP-cone domain that allosterically controls overall activity. In this study, we report the emergence of a distinct and unexpected mechanism of activity regulation in the sole RNR of the model organism Bacillus subtilis. Using a hypothesis-driven structural approach that combines the strengths of small-angle X-ray scattering (SAXS), crystallography, and cryo-electron microscopy (cryo-EM), we describe the reversible interconversion of six unique structures, including a flexible active tetramer and two inhibited helical filaments. These structures reveal the conformational gymnastics necessary for RNR activity and the molecular basis for its control via an evolutionarily convergent form of allostery.

Indexed as

Allosteric RegulationAllosteric SiteBacillus subtilisBacterial ProteinsCryoelectron MicroscopyCrystallography, X-RayEvolution, MolecularModels, MolecularProtein Structure, QuaternaryRibonucleotide ReductasesRibonucleotidesScattering, Small AngleBacterial ProteinsRibonucleotide ReductasesRibonucleotides

Identifiers

PMID31201319
PMCPMC6572854
OpenAlexW2952542962

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.